ReviewIndian journal of dermatology
Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects.
Review in Indian journal of dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.
- Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis.Anais brasileiros de dermatologiaPooled it
- Causal relationship between trace elements and pityriasis rosea: A Mendelian randomization analysis.Medicine · 2026Article
- Article
- The risks of pityriasis rosea in pregnancy: a review.International journal of women's dermatology · 2025Review
- Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea.American journal of clinical dermatology · 2025Review
- Article
- Serum Interleukin-36 in Pityriasis Rosea: A Potential Biomarker for Disease Severity.The Journal of clinical and aesthetic dermatology · 2023Article
- Article
- Pityriasis Rosea Induced by COVID-19 Vaccination.European journal of case reports in internal medicine · 2022Article
- Inverse pityriasis rosea secondary to COVID-19 vaccination.Proceedings (Baylor University. Medical Center) · 2022Article
- CD123 immunoexpression in cutaneous lupus erythematosus, polymorphous light eruption, pityriasis rosea, and mycosis fungoides.Postepy dermatologii i alergologii · 2021Article
- Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.Dermatologic therapy · 2021Article
- Pemphigus Vulgaris After COVID-19: a Case of Induced Autoimmunity.SN comprehensive clinical medicine · 2021Article
- Management guidelines for pregnant health care workers exposed to infectious dermatoses.International journal of women's dermatology · 2020Review
- Recurrent pityriasis rosea: A case report.Human vaccines & immunotherapeutics · 2018Article
- Article
- Clinical variants of pityriasis rosea.World journal of clinical cases · 2017Review
- [Paraviral exanthems].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2017Review
- A Cross-Sectional Study of Epidemiological and Clinical Aspects of Pityriasis Rosea along with Dermoscopic Analysis and Histopathology Correlation.Indian journal of dermatologyArticle
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications.Journal of cutaneous medicine and surgeryReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pityriasis rosea (PR) is a benign papulosquamous disorder seen commonly in clinical practice. Despite its prevalence and benign nature, there are still times when this common disorder presents in an uncommon way or course posing diagnostic or management problems for the treating physician. The etiopathogenesis of PR has always been a dilemma, and extensive research is going on to elicit the exact cause. This review focuses mainly on the difficult aspects of this benign common disorder such as etiopathogenesis, atypical manifestations, recurrent cases, differential diagnosis, therapy and pregnancy considerations. Although we could not find a black and white solution to all these problems, we have tried to compile the related literature to draw out some conclusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.